J.P. Morgan Maintains Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Cuts Target Price to $48

Futu NewsJan 8 21:30 · Ratings

Wedbush Maintains Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Maintains Target Price $32

Futu NewsJan 6 21:34 · Ratings

Buy Recommendation for Rocket Pharmaceuticals: Promising Potential of RP-L301 in Severe PKD Cases

TipRanksJan 6 21:25

Top 3 Health Care Stocks That Could Blast Off This Month

BenzingaJan 6 20:19

BofA Securities Maintains Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Maintains Target Price $37

Futu NewsJan 6 19:31 · Ratings

Rocket Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

BusinesswireJan 3 05:00